CCEL stock · TECH stock

CCEL vs TECH

CryoCell International Inc (CCEL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

CryoCell International Inc (CCEL) is a medical care facilities company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

CCEL does not have a complete income-statement cache yet.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

CCEL currently screens at market cap $39.6M and trailing P/E 490.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the CCEL and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons